Drugs / Peginterferon a-2a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00215839 | — | HIV infectious disease, chronic hepatitis C virus infection | Hepatitis Resource Network | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peginterferon a-2a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00215839 ↗ |
| Route | Subcutaneous | “Peginterferon a-2a 180mg by subcutaneous route once weekly” NCT00215839 ↗ |